DELTA 9 CANNABIS INC. (TSXV: NINE) ("Delta 9" or the "Company") is pleased to announce that Health Canada has approved the Company's application for an amendment to its cannabis production and sale license which will allow it to produce bottled cannabis oils under the Access to Cannabis for Medical Purposes Regulations (the "ACMPR"). The license amendment was issued on April 20, 2018 and is valid until August 30, 2019.
The cannabis sector has been under pressure and this weakness has been taking place on lighter-than normal volume. Earlier this month, we highlighted this trend as something investors need to watch and we continue to monitor trading activity due to the recent increase in selling-pressure.
DELTA 9 CANNABIS INC. (TSXV: NINE) is pleased to announce that the Company has signed a non-binding letter of intent (the "LOI") with CanPharma GMBH ("CanPharma") and Global Group Kalapa S.L. ("Kalapa") for the exportation of medical cannabis to Germany.
Delta 9 Cannabis Inc. (TSXV:NINE) ("Delta 9" or the "Company") is pleased to announce it has entered into a non-binding letter of intent (the "LOI") with Westleaf Cannabis Inc. ("Westleaf") to create a strategic partnership for the joint development of a large-scale cannabis production facility located in Southern Alberta (the "Project").
Canopy Growth Corporation (TSX:WEED) and Delta 9 Cannabis Inc. (TSX.V:NINE) applaud the framework today announced by the Province of Manitoba regarding adult-use cannabis production, distribution, and retail.